Po–Sung Chu

2.0k citations

42 papers · 825 indexed · 1 hit paper · h-index 15

Co-authors: Takanori Kanai∥Nobuhiro Nakamoto Hirotoshi Ebinuma Nobuhito Taniki Yohei Mikami Hidetsugu Saito Toshifumi Hibi∥Toshiaki Teratani
Topics: Liver Disease Diagnosis and Treatment (24 papers)Liver Disease and Transplantation (11 papers)Immune Cell Function and Interaction (9 papers)
Cited by: Hepatology Epidemiology Immunology
Journals: Journal of Clinical Investigation Nature Communications Gastroenterology
Partner nations: Japan United States Germany

In The Last Decade

Po–Sung Chu

40 papers receiving 809 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells

2021 147 citations Yuzo Koda, Toshiaki Teratani et al. profile →

Peers

Countries citing papers authored by Po–Sung Chu

Since Specialization

Citations

This map shows the geographic impact of Po–Sung Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po–Sung Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po–Sung Chu more than expected).

Fields of papers citing papers by Po–Sung Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po–Sung Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po–Sung Chu. The network helps show where Po–Sung Chu may publish in the future.

Co-authorship network of co-authors of Po–Sung Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Po–Sung Chu. A scholar is included among the top collaborators of Po–Sung Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po–Sung Chu. Po–Sung Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Successful treatment of refractory enteritis and arthritis with combination of tumour necrosis factor and interleukin-6 inhibition in patients with ulcerative colitis 2023 ·Modern Rheumatology Case Reports ·Sho Ishigaki,Yasushi Kondo,(unknown),Po–Sung Chu,Hironari Hanaoka,Tsutomu Takeuchi,Yuko Kaneko	1
2	Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis 2023 ·iScience ·(unknown),Po–Sung Chu,Nobuhiro Nakamoto,Yuya Hagihara,Yohei Mikami,Kentaro Miyamoto,Rei Morikawa,Toshiaki Teratani,Nobuhito Taniki,(unknown),Takahiro Suzuki,Yuzo Koda,(unknown),Masataka Ichikawa,Akira Honda,Takanori Kanai∥	7
3	IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis 2023 ·JHEP Reports ·(unknown),Po–Sung Chu,Toshiaki Teratani,Yosuke Harada,Takahiro Suzuki,(unknown),Nobuhito Taniki,(unknown),Yohei Mikami,Yuzo Koda,Masataka Ichikawa,(unknown),Rei Morikawa,(unknown),(unknown),Hanako Tsujikawa,Yutaka Kurebayashi,Michiie Sakamoto,Takanori Kanai∥,Nobuhiro Nakamoto	3
4	Successful Case of Deceased Donor Liver Transplant for Polycystic Liver Disease 2022 ·Transplantation Proceedings ·Hisashi Sugimoto,Yôichi Ôshima,Yuki Oba,(unknown),Akinari Sekine,Hiroki Mizuno,Masayuki Yamanouchi,Eiko Hasegawa,Tatsuya Suwabe,Po–Sung Chu,Yasushi Hasegawa,Hideaki Obara,Naoki Sawa,Yoshifumi Ubara	3
5	Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts 2022 ·PLoS ONE ·(unknown),Po–Sung Chu,Yuzo Koda,Nobuhito Taniki,Rei Morikawa,Aya Yoshida,(unknown),(unknown),(unknown),Hirotoshi Ebinuma,Takanori Kanai∥,Nobuhiro Nakamoto	0
6	CCR9 axis inhibition enhances hepatic migration of plasmacytoid DCs and protects against liver injury 2022 ·JCI Insight ·Yuzo Koda,Nobuhiro Nakamoto,Po–Sung Chu,Toshiaki Teratani,Akihisa Ueno,(unknown),Nobuhito Taniki,(unknown),Kentaro Miyamoto,Michiie Sakamoto,Takanori Kanai∥	5
7	Th17 cells in the liver: balancing autoimmunity and pathogen defense 2022 ·Seminars in Immunopathology ·Nobuhito Taniki,Nobuhiro Nakamoto,Po–Sung Chu,Masataka Ichikawa,Toshiaki Teratani,Takanori Kanai∥	11
8	Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis 2021 ·PLoS ONE ·(unknown),Po–Sung Chu,Aya Yoshida,Nobuhito Taniki,Rei Morikawa,(unknown),(unknown),(unknown),(unknown),Hirotoshi Ebinuma,Hidetsugu Saito,Takanori Kanai∥,Nobuhiro Nakamoto	4
9	Early Dynamics of MELD Scores Predict Corticosteroid Responsiveness to Severe Acute-Onset Autoimmune Hepatitis 2021 ·Clinical Gastroenterology and Hepatology ·(unknown),Po–Sung Chu,Aya Yoshida,Nobuhito Taniki,Rei Morikawa,Yasushi Hasegawa,(unknown),(unknown),(unknown),(unknown),Hirotoshi Ebinuma,Masahiro Shinoda,Hideaki Obara,Yuko Kitagawa,Takanori Kanai∥,Nobuhiro Nakamoto	5
10	A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity 2020 ·Clinical Nutrition ESPEN ·Kazuhiro Kashiwagi,Michiyo Takayama,(unknown),Ryoko Shimizu‐Hirota,Po–Sung Chu,Nobuhiro Nakamoto,Nagamu Inoue,Yasushi Iwao,Takanori Kanai∥	22
11	Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study 2020 ·BMC Gastroenterology ·Shunsuke Shiba,Po–Sung Chu,Nobuhiro Nakamoto,(unknown),Nobuhito Taniki,Keisuke Ojiro,Akihiro Yamaguchi,Rei Morikawa,Aya Yoshida,(unknown),Hirotoshi Ebinuma,Hidetsugu Saito,Takanori Kanai∥	6
12	Late-onset acute liver failure due to Wilson’s disease managed by plasmapheresis and hemodiafiltration successfully serving as a bridge for deceased donor liver transplantation: a case report and literature review 2020 ·Clinical Journal of Gastroenterology ·(unknown),Po–Sung Chu,Masahiro Shinoda,Taizo Hibi,Nobuhito Taniki,Aya Yoshida,Miho Kawaida,(unknown),Rei Morikawa,(unknown),Shu Wakino,Kaori Kameyama,Hideaki Obara,Yuko Kitagawa,Hidetsugu Saito,Takanori Kanai∥,Nobuhiro Nakamoto	6
13	Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis 2020 ·Journal of Hepatology ·Rei Morikawa,Nobuhiro Nakamoto,(unknown),Po–Sung Chu,Yuzo Koda,Toshiaki Teratani,Takahiro Suzuki,Yutaka Kurebayashi,Akihisa Ueno,Nobuhito Taniki,Kentaro Miyamoto,Akihiro Yamaguchi,Shunsuke Shiba,Tadashi Katayama,Kosuke Yoshida,Yoshiaki Takada,(unknown),Hirotoshi Ebinuma,Michiie Sakamoto,Takanori Kanai∥	30
14	Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35 2019 ·Journal of Clinical Investigation ·Yuzo Koda,Nobuhiro Nakamoto,Po–Sung Chu,(unknown),Yohei Mikami,Toshiaki Teratani,Hanako Tsujikawa,Shunsuke Shiba,Nobuhito Taniki,Tomohisa Sujino,Kentaro Miyamoto,Takahiro Suzuki,Akihiro Yamaguchi,Rei Morikawa,Katsuaki Sato,Michiie Sakamoto,Takayuki Yoshimoto,Takanori Kanai∥	29
15	On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C 2017 ·PLoS ONE ·Po–Sung Chu,Nobuhiro Nakamoto,Nobuhito Taniki,Keisuke Ojiro,(unknown),Yuko Makita,Hiroko Murata,Akihiro Yamaguchi,Shunsuke Shiba,(unknown),Tadashi Katayama,(unknown),(unknown),(unknown),Hirotoshi Ebinuma,Hidetsugu Saito,Takanori Kanai∥	51
16	Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis 2017 ·BMC Gastroenterology ·Shingo Usui∥,Hirotoshi Ebinuma,Po–Sung Chu,Nobuhiro Nakamoto,Yoshiyuki Yamagishi,Hidetsugu Saito,Takanori Kanai∥	5
17	Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/ Ribavirin Therapy in Chronic Hepatitis C 2015 ·PLoS ONE ·Po–Sung Chu,Hirotoshi Ebinuma,Nobuhiro Nakamoto,Kazuo Sugiyama,Shingo Usui∥,(unknown),Nobuhito Taniki,Akihiro Yamaguchi,Shunsuke Shiba,Yoshiyuki Yamagishi,Takaji Wakita,Toshifumi Hibi∥,Hidetsugu Saito,Takanori Kanai∥	2
18	Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus 2014 ·PLoS ONE ·Kazuo Sugiyama,Hirotoshi Ebinuma,Nobuhiro Nakamoto,(unknown),Yuko Murakami,Po–Sung Chu,Shingo Usui∥,(unknown),(unknown),Nobuhito Taniki,Hiroko Murata,Yoshimasa Saito,Masayoshi Fukasawa,Kyoko Saito,Yoshiyuki Yamagishi,Takaji Wakita,Hiroshi Takaku,Toshifumi Hibi∥,Hidetsugu Saito,Takanori Kanai∥	37
19	IL-22-Producing RORγt-Dependent Innate Lymphoid Cells Play a Novel Protective Role in Murine Acute Hepatitis 2013 ·PLoS ONE ·(unknown),Takanori Kanai∥,Yohei Mikami,Po–Sung Chu,Nobuhiro Nakamoto,Hirotoshi Ebinuma,Hidetsugu Saito,Toshiro Sato,Hideo Yagita∥,Toshifumi Hibi∥	30
20	CCR9+ Macrophages Are Required for Acute Liver Inflammation in Mouse Models of Hepatitis 2011 ·Gastroenterology ·Nobuhiro Nakamoto,Hirotoshi Ebinuma,Takanori Kanai∥,Po–Sung Chu,Yūichi Ono,Yohei Mikami,Keisuke Ojiro,Martin Lipp,Paul E. Love,Hidetsugu Saito,Toshifumi Hibi∥	75

About Po–Sung Chu

Po–Sung Chu is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 42 papers that have together received 825 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (11 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Hepatology (343 citations), Epidemiology (442 citations) and Immunology (242 citations). Po–Sung Chu has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Takanori Kanai∥, Nobuhiro Nakamoto, Hirotoshi Ebinuma, Nobuhito Taniki, Yohei Mikami, Hidetsugu Saito, Toshifumi Hibi∥, Toshiaki Teratani, Keisuke Ojiro and Michiie Sakamoto. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact